# Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

> **NCT04039724** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 61 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HCP0605 + HGP0816
- **DRUG:** HCP1305

## Key facts

- **NCT ID:** NCT04039724
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2019-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04039724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04039724, "Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT04039724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*